The course of Helicobacter pylori infection in kidney transplantation patients

Scandinavian Journal of Gastroenterology

Volumn 38, Issue 1, 2003, Pages 20-26

  Sarkio, S ^a,b,c   Rautelin, H ^a,b,c   Halme, Leena ^a,b,c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Lohja Hospital   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Eradication; Helicobacter pylori; Transplantation

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CAGA PROTEIN; CEFAMANDOLE; CYCLOSPORIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PEPSINOGEN I; RANITIDINE; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; GASTROENTERITIS; HELICOBACTER PYLORI; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RISK FACTOR; SERODIAGNOSIS;

EID: 0037261255     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365521.2003.11800652     Document Type: Article

References (36)

1. Gisbert J, Blanco M, Mateos J, et al. H. pylori-negative duodenal ulcer prevalence and causes in 744 patients. Dig Dis Sci 1999;44:2295-301.
2. Perez-Perez G, Bhat N, Gaensbauer J, et al. Country specific constancy by age in cagA+proportion of Helicobacter pylori infections. Int J Cancer 1997;72:453-6.
3. Axon A. Are all helicobacters equal? Mechanism of gastroduodenal pathology and their clinical implications. Gut 1999;45 Suppl:I:1-4.
4. Parsonnet J, Friedman GD, Orentrich N, Vogelman H. Risk for gastric cancer in people with cagA positive or cagA negative Helicobacter pylori infection. Gut 1997;40:297-301.
5. Atherton J. H. pylori virulence factors. Br Med Bull 1998;54:105-20.
6. Blaser M, Perez-Perez G, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-5.
7. Asaka M, Kimura T, Kudo M, et al. Relationship of H. pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992;102:760-6.
8. Biasco G, Paganelli G, Vaira D, et al. Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pylori in dyspeptic patients. J Clin Pathol 1993;46:826-8.
9. Karnes W, Samloff I, Siurala M, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101:167-74.
10. Owens M, Passaro E, Wilson S, Gordon H. Treatment of peptic ulcer disease in the renal transplant patients. Ann Surg 1977;186:17-21.
11. Ahonen J, Eklund B, Lindfors O, Kuhlbäck B, Lindström B. Peptic ulceration in kidney transplantation. Proc Eur Dial Transplant Assoc 1977;14:396-400.
12. Gladziva U, Haase G, Handt S, et al. Prevalence of Helicobacter pylori in patients with renal failure. Nephrol Dial Transplant 1993;8:301-6.
13. Özgur O, Boyacioglu M, Gur G. Helicobacter pylori infection in hemodialysis patients and renal transplant recipients. Nephrol Dial Transplant 1997;12:289-91.
14. Davenport A, Shallcross T, Crabtree J, Davison A, Will E, Heatley R. Prevalence of Helicobacter pylori in patients with end-stage renal failure and renal transplant recipients. Nephron 1991;59:597-601.
15. Sarkio S, Rautelin H, Kyllönen L, Honkanen E, Salmela K, Halme L. Should Helicobacter pylori infection be treated before kidney transplantation? Nephrol Dial Transplant 2001;16:2053-7.
16. Opelz G. Immunosuppression with FK 506 does not improve kidney graft survival. Transplant Proc 1999;31:1147-8.
17. Kosunen T, Seppälä K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893-5.
18. Oksanen A, Veijola L, Sipponen P, Schauman K-O, Rautelin H. Evaluation of Pyloriset Screen, a rapid whole-blood diagnostic test for Helicobacter pylori infection. J Clin Microbiol 1998;36:955-7.
19. Oksanen A, Sipponen P, Karttunen R, et al. Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut 2000;46:460-3.
20. Graham D, Klein P, Evans D, et al. Campylobacter pylori detected noninvasively by the 13 urea breath test. Lancet 1987:i:1174-7.
21. Kosunen T, Aromaa A, Knekt P, et al. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect 1997;119:29-34.
22. Perez Perez G, Cutler A, Blaser M. Value of serology as a noninvasive method for evaluating the efficiancy of treatment of Helicobacter pylori infection. Clin Infect Dis 1997;25:1038-43.
23. Lerang F, Haug J, Moum B, et al. Accuracy of IgG serology and other tests in confirming Helicobacter pylori eradication. Scand J Gastroenterol 1998;33:710-5.
24. Hirschl A, Brandstätter G, Dragosics B, et al. Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy. J Infect Dis 1993;168:763-6.
25. Cutler A, Prasad M, Santogade P. Four-year trends in Helicobacter pylori IgG serology following successful eradication. Am J Med 1998;105:18-20.
26. Technical annex: tests used to assess Helicobacter pylori infection. Gut 1997;41 Suppl 2:10-8.
27. Dummer J, Perez-Perez G, Breinig M, et al. Seroepidemiology of Helicobacter pylori infection in heart transplant recipients. Clin Infect Dis 1995;21:1303-5.
28. Rudi J, Engler S, Theilman L, Otto G, Stremmel W. Prevalence of serum antibodies to Helicobacter pylori and to CagA protein in liver transplant recipients. Am J Gastroenterol 1997;92:1492-5.
29. Arnold W, Steele R, Rastogi S, et al. Response to pneumococcal vaccine in renal allograft recipients. Am J Nephrol 1985;5:30-4.
30. Jaskowski T, Martins T, Hill H, Litwin C. Immunoglobulin A antibodies to Helicobacter pylori. J Clin Microbiol 1997;35:2999-3000.
31. Gun M, Stephens J, Stewart J, Rathbone B, West K. The significance of CagA and VacA subtypes of Helicobacter pylori in the pathogenesis of inflammation and peptic ulceration. J Clin Pathol 1998;51:761-4.
32. Rautelin H, Oksanen A, Karttunen R, et al. Association of CagA-positive infection with Helicobacter pylori antibodies of IgA class. Ann Med 2000;32:625-56.
33. Perez Perez G, Salomaa A, Kosunen T, et al. Evidence that cagA+ Helicobacter pylori strains are disappearing more rapidly than cagA-strains. Gut 2002;50:295-8.
34. Tamura H, Tokushima H, Murakawa M, et al. Influences of Helicobacter pylori on serum pepsinogen concentrations in dialysis patients. Nephrol Dial Transplant 1999;14:113-7.
35. Araki H, Miyazaki R, Matsuda T, Gejyo F, Koni I. Significance of serum pepsinogens and their relationship to Helicobacter pylori infection and histological gastritis in dialysis patients. Nephrol Dial Transplant 1999;14:2669-75.
36. Navaglia F, Basso D, Piva M, et al. Helicobacter pylori cytotoxic genotype is associated with peptic ulcer and influences serology. Am J Gastroenterol 1998;93:227-30.